STERIS Long Term Debt 2010-2022 | STE
STERIS long term debt from 2010 to 2022. Long term debt can be defined as the sum of all long term debt fields.
- STERIS long term debt for the quarter ending December 31, 2022 was $3.002B, a 5.47% decline year-over-year.
- STERIS long term debt for 2022 was $2.945B, a 78.46% increase from 2021.
- STERIS long term debt for 2021 was $1.651B, a 43.46% increase from 2020.
- STERIS long term debt for 2020 was $1.151B, a 2.76% decline from 2019.
STERIS Annual Long Term Debt (Millions of US $) |
2022 |
$2,945 |
2021 |
$1,651 |
2020 |
$1,151 |
2019 |
$1,183 |
2018 |
$1,316 |
2017 |
$1,478 |
2016 |
$1,568 |
2015 |
$621 |
2014 |
$493 |
2013 |
$492 |
2012 |
$210 |
2011 |
$210 |
2010 |
$210 |
2009 |
$210 |
STERIS Quarterly Long Term Debt (Millions of US $) |
2022-12-31 |
$3,002 |
2022-09-30 |
$2,874 |
2022-06-30 |
$2,846 |
2022-03-31 |
$2,945 |
2021-12-31 |
$3,175 |
2021-09-30 |
$3,422 |
2021-06-30 |
$3,257 |
2021-03-31 |
$1,651 |
2020-12-31 |
$1,713 |
2020-09-30 |
$1,021 |
2020-06-30 |
$1,022 |
2020-03-31 |
$1,151 |
2019-12-31 |
$1,137 |
2019-09-30 |
$1,187 |
2019-06-30 |
$1,210 |
2019-03-31 |
$1,183 |
2018-12-31 |
$1,246 |
2018-09-30 |
$1,268 |
2018-06-30 |
$1,320 |
2018-03-31 |
$1,316 |
2017-12-31 |
$1,420 |
2017-09-30 |
$1,445 |
2017-06-30 |
$1,496 |
2017-03-31 |
$1,478 |
2016-12-31 |
$1,507 |
2016-09-30 |
$1,504 |
2016-06-30 |
$1,552 |
2016-03-31 |
$1,568 |
2015-12-31 |
$1,639 |
2015-09-30 |
$830 |
2015-06-30 |
$686 |
2015-03-31 |
$621 |
2014-12-31 |
$611 |
2014-09-30 |
$620 |
2014-06-30 |
$659 |
2014-03-31 |
$493 |
2013-12-31 |
$475 |
2013-09-30 |
$509 |
2013-06-30 |
$514 |
2013-03-31 |
$492 |
2012-12-31 |
$521 |
2012-09-30 |
$434 |
2012-06-30 |
$210 |
2012-03-31 |
$210 |
2011-12-31 |
$210 |
2011-09-30 |
$210 |
2011-06-30 |
$210 |
2011-03-31 |
$210 |
2010-12-31 |
$210 |
2010-09-30 |
$210 |
2010-06-30 |
$210 |
2010-03-31 |
$210 |
2009-12-31 |
$310 |
2009-09-30 |
$210 |
2009-06-30 |
$210 |
2009-03-31 |
$210 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
Medical Instruments Manufacturing |
$18.499B |
$4.585B |
STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.
|